Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
Phase 2
Terminated
- Conditions
- Coronary Heart DiseaseChlamydophila Pneumoniae Infections
- Interventions
- Drug: Placebo oral capsuleDrug: Placebo Oral Tablet
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Cadrock Pty. Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT03618108
- Locations
- 🇦🇺
Liverpool hospital, Liverpool, New South Wales, Australia
News
No news found